Literature DB >> 30237086

The combination of fecal calprotectin with ESR, CRP and albumin discriminates more accurately children with Crohn's disease.

Urszula Daniluk1, Jaroslaw Daniluk2, Milena Krasnodebska3, Joanna Maria Lotowska4, Maria Elzbieta Sobaniec-Lotowska4, Dariusz Marek Lebensztejn3.   

Abstract

PURPOSE: Increased fecal calprotectin is a sensitive marker of various types of intestinal inflammation. We investigated correlations between high fecal calprotectin concentration and serum inflammatory markers in children with different intestinal diseases with diarrhea with/without blood and/or abdominal pain, to test whether the combination of these markers can differentiate potential patients with inflammatory bowel disease. MATERIALS/
METHODS: The study included 128 children with high fecal calprotectin concentration (>150ug/g) and symptoms suggesting bowel disorders, hospitalized in the years 2013- 2015. Twenty-six (20%) patients were diagnosed with Crohn's disease, 55 (43%) with ulcerative colitis, 32 (25%) with intestinal infection and 15 (12%) with food protein induced proctocolitis.
RESULTS: Significantly increased inflammatory markers were detected in children with inflammatory bowel disease, with a correlation between calprotectin and erythrocyte sedimentation rate - ESR (R = 0.53), mean corpuscular volume - MCV (R=-0.64), red blood cell distribution width (R = 0.56), albumin (R = -0.52), hemoglobin (R = -0.53) only in Crohn's disease patients. To discriminate Crohn's disease patients from patients with intestinal infection and patients with food protein induced proctocolitis, AUC analysis was performed. It revealed that considering ESR, CRP and albumin as additional markers to fecal calprotectin significantly improved diagnostic performance (AUC 0.917, p = 0.038).
CONCLUSIONS: In children with abdominal pain and/or diarrhea, increased ESR, CRP and decreased albumin combined with a high fecal calprotectin level yields additional diagnostic value in screening potential patients with Crohn's disease. As far as differentiation of ulcerative colitis is concerned, low additional diagnostic value was found when high fecal calprotectin was combined with albumin.
Copyright © 2018 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Calprotectin; Crohn’s disease; Food protein induced proctocolitis; Intestinal infection; Ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 30237086     DOI: 10.1016/j.advms.2018.08.001

Source DB:  PubMed          Journal:  Adv Med Sci        ISSN: 1896-1126            Impact factor:   3.287


  11 in total

1.  C-Reactive Protein/Albumin Ratio at Diagnosis of Pediatric Inflammatory Bowel Disease: A Retrospective Multi-Center Study.

Authors:  Aleksandra Glapa-Nowak; Mariusz Szczepanik; Aleksandra Banaszkiewicz; Jarosław Kwiecień; Anna Szaflarska-Popławska; Urszula Grzybowska-Chlebowczyk; Marcin Osiecki; Jarosław Kierkuś; Marcin Dziekiewicz; Jarosław Walkowiak
Journal:  Med Sci Monit       Date:  2022-09-14

2.  Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis?

Authors:  Aleksandra Czajkowska; Katarzyna Guzinska-Ustymowicz; Anna Pryczynicz; Dariusz Lebensztejn; Urszula Daniluk
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.964

3.  Differentiation of Isolated Small Bowel Crohn's Disease from Other Small Bowel Ulcerative Diseases: Clinical Features and Double-Balloon Enteroscopy Characteristics.

Authors:  Meng Niu; Zheng-Hao Chen; Meng Li; Xing Zhang; Chun-Xiao Chen
Journal:  Gastroenterol Res Pract       Date:  2022-05-30       Impact factor: 1.919

4.  The Relationship between C-Reactive Protein/Albumin Ratio and Disease Activity in Patients with Inflammatory Bowel Disease.

Authors:  Yi-Han Chen; Li Wang; Shu-Yi Feng; Wei-Min Cai; Xiao-Fu Chen; Zhi-Ming Huang
Journal:  Gastroenterol Res Pract       Date:  2020-06-22       Impact factor: 2.260

5.  The assessment of plasma fatty acid profiles in newly diagnosed treatment-naive paediatric Crohn's disease.

Authors:  J Schwarz; M Vecka; F Stožický; R Pomahačová; B Staňková; E Tvrzická; M Kreslová; R Zahálková; J Sýkora
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

6.  Sphingolipid Analysis Indicate Lactosylceramide as a Potential Biomarker of Inflammatory Bowel Disease in Children.

Authors:  Aleksandra Filimoniuk; Agnieszka Blachnio-Zabielska; Monika Imierska; Dariusz Marek Lebensztejn; Urszula Daniluk
Journal:  Biomolecules       Date:  2020-07-21

7.  Cathelicidin - A Novel Potential Marker of Pediatric Inflammatory Bowel Disease.

Authors:  Paulina Krawiec; Elżbieta Pac-Kożuchowska
Journal:  J Inflamm Res       Date:  2021-01-22

8.  Predictive value of fibrinogen in identifying inflammatory bowel disease in active stage.

Authors:  Xiao-Fu Chen; Yuan Zhao; Yu Guo; Zhi-Ming Huang; Xie-Lin Huang
Journal:  BMC Gastroenterol       Date:  2021-12-15       Impact factor: 3.067

Review 9.  Pancreatic Disorders in Children with Inflammatory Bowel Disease.

Authors:  Piotr Jakimiec; Katarzyna Zdanowicz; Kamila Kwiatek-Sredzinska; Aleksandra Filimoniuk; Dariusz Lebensztejn; Urszula Daniluk
Journal:  Medicina (Kaunas)       Date:  2021-05-11       Impact factor: 2.430

Review 10.  Neutrophil-T cell crosstalk in inflammatory bowel disease.

Authors:  Egle Kvedaraite
Journal:  Immunology       Date:  2021-07-20       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.